[responsivevoice_button voice=”UK English Female” buttontext=”Listen to Post”]
Researchers have discovered the pharmacological drug, Naltrexone, significantly restored the function of faulty receptors associated with myalgic encephalomyelitis, also known as Chronic Fatigue Syndrome (ME/CFS).
Researchers from the National Centre for Neuroimmunology and Emerging Diseases (NCNED), Menzies Health Institute Queensland, Griffith University led the research, which has been published in Frontiers in Immunology.
Click here to read full article https://www.miragenews.com/researchers-discover-potential-therapeutic-approach-to-treat-me-cfs/
